These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 13959698)

  • 1. Favorable response of metastatic adenocarcinoma of the corpus to massive progrestational therapy: report of a case.
    FRICK HC; SOUTHAM AL; AZAR HA
    Bull Sloane Hosp Women Columbia Presbyt Med; 1963; 9():10-6. PubMed ID: 13959698
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical and histopathologic evaluation of the effect of 17-alpha-hydroxyprogesterone-17-n-caproate on endometral carcinoma.
    VARGA A; HENRIKSEN E
    Obstet Gynecol; 1961 Dec; 18():658-72. PubMed ID: 13924838
    [No Abstract]   [Full Text] [Related]  

  • 3. [PROGESTINICS AND ADENOCARCINOMA OF THE ENDOMETRIUM].
    ACCINELLI G
    Clin Ostet Ginecol; 1964 Jul; 66():379-98. PubMed ID: 14221824
    [No Abstract]   [Full Text] [Related]  

  • 4. EFFECT OF 17-ALPHA-HYDROXYPROGESTERONE 17-N-CAPROATE ON VARIOUS PELVIC MALIGNANCIES.
    VARGA A; HENRIKSEN E
    Obstet Gynecol; 1964 Jan; 23():51-62. PubMed ID: 14110061
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of progestin therapy on the level of cytoplasmic receptors in patients with cancer of the corpus uteri].
    Vishnevskiĭ AS; Bokhman IaV; Tsyrlina EV; Bobrov IuF; Fel'dkoren BI
    Vopr Onkol; 1989; 35(5):594-8. PubMed ID: 2545046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hormofort in the treatment of metastatic adenocarcinoma of corpus uteri].
    Kaliński R; Wlodarski A
    Wiad Lek; 1972 Oct; 25(20):1903-5. PubMed ID: 4643245
    [No Abstract]   [Full Text] [Related]  

  • 7. A progestogen for treatment of advanced endometrial cancer.
    KENNEDY BJ
    JAMA; 1963 Jun; 184():758-61. PubMed ID: 14031934
    [No Abstract]   [Full Text] [Related]  

  • 8. PROGESTERONE AND PROGESTATIONAL COMPOUNDS IN THE TREATMENT OF ADVANCED ENDOMETRIAL CARCINOMA.
    BERGSJOE P
    Acta Endocrinol (Copenh); 1965 Jul; 49():412-26. PubMed ID: 14317884
    [No Abstract]   [Full Text] [Related]  

  • 9. [Progestins in combined treatment of endometrial cancer].
    Voznyĭ EK; Titova VA
    Sov Med; 1990; (9):102-7. PubMed ID: 2148437
    [No Abstract]   [Full Text] [Related]  

  • 10. PROLONGED POSTPARTUM DYSFUNCTIONAL UTERINE BLEEDING SUBSEQUENT TO PRENATAL THERAPY WITH PARENTERAL POTENT PROGESTOGENS.
    TURNER SJ
    Obstet Gynecol; 1964 Aug; 24():218-21. PubMed ID: 14199528
    [No Abstract]   [Full Text] [Related]  

  • 11. [Study of hepatic function and carbohydrate metabolism during therapy with 6-alpha-methyl-17-alpha-hydroxyprogesterone acetate in adenocarcinoma of the uterine body. II. Influence on carbohydrate metabolism].
    Lanza A
    Minerva Ginecol; 1969 Dec; 21(23):1624-31. PubMed ID: 5373231
    [No Abstract]   [Full Text] [Related]  

  • 12. [Synthetic progestins in combined treatment of cancer of the uterine body].
    Iatskovskai NL
    Vopr Onkol; 1976; 22(3):25-8. PubMed ID: 936523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of treatment with oral 6-methyl-17-hydroxyprogesterone acetate in endometrial adenocarcinoma. Histochemical and ultrastructural aspects].
    Vecchietti G; Gerzeli G; Zanoio L; Novelli GG; Barni S; Patton R
    Minerva Ginecol; 1981 Apr; 33(4):293-306. PubMed ID: 7243070
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of metastasizing carcinoma of the uterus with gestagens].
    Engeler V
    Schweiz Med Wochenschr; 1971 Dec; 101(52):1906-9. PubMed ID: 5141283
    [No Abstract]   [Full Text] [Related]  

  • 15. [PROGESTOGENS AND ADENOCARCINOMA OF THE ENDOMETRIUM].
    PIACENTINI G
    Clin Ter; 1963 Sep; 26():491-7. PubMed ID: 14089592
    [No Abstract]   [Full Text] [Related]  

  • 16. [Combination with medroxyprogesterone acetate and chemotherapy making possible complete removal of uterine corpus carcinoma].
    Tajima H; Okada T; Fujimori Y; Tomioka Y; Hirano M; Yoshida T; Ikeda S; Hata T
    Gan To Kagaku Ryoho; 1989 Jul; 16(7):2461-4. PubMed ID: 2526620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Adenocarcinoma of the endometrium while undergoing contraceptive treatment with medroxyprogesterone].
    Stamm H; De Grandi P
    Rev Med Suisse Romande; 1981 Nov; 101(11):913-7. PubMed ID: 7323568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of 19-nor-17 alpha-hydroxyprogesterone caproate in endometrial cancer].
    Márquez J; Dabancens A; González O; Rosmanich A
    Rev Chil Obstet Ginecol; 1976; 41(5):304-11. PubMed ID: 1030512
    [No Abstract]   [Full Text] [Related]  

  • 19. Vaginal cytologic evaluation as a practical link between hormone blood levels and tumor hormone dependency in exclusive medroxyprogesterone treatment of recurrent or metastatic endometrial adenocarcinoma.
    Bonte J; Decoster JM; Ide P
    Acta Cytol; 1977; 21(2):218-24. PubMed ID: 266331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination chemotherapy of advanced endometrial adenocarcinoma with adriamycin, cyclophosphamide, 5-fluorouracil, and medroxyprogesterone acetate.
    Bruckner HW; Deppe G
    Obstet Gynecol; 1977 Jul; 50(1 Suppl):10s-12s. PubMed ID: 876531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.